의약품 독점제도와 한미FTA

건강세상네트워크 등에서 강연할 때 사용했던 자료입니다.

hurips – 금, 2006 – 07 – 21 04:32

U.S. government pushed Korea to drop new drug policy

U.S. government pushed Korea to drop new drug policy
Written by Heeseob Nam (hurips@gmail.com)
July 21, 2006

Alexander Vershbow, U.S. Ambassador to the Republic of Korea, visited Korean Ministry of Public Health on July 19 and had a meeting with Korean Minister (Mr. Yoo). On July 18, Mr. Vershbow requested the meeting and the purposes of his visit are to deliver U.S. government’s concerns on the drug pricing policy of Korean government. On May, the Korean government announced to reform its drug pricing policy of the national healthcare system by adopting measures to positively list reimbursable prescription drugs rather than the current “negative list”, which only lists the exclusions. During the second round of the KORUS FTA, the US negotiators expressed its strong opposition to the positive list system and refused to attend the Pharmaceutical and Medical Device Working Group meeting.

hurips – 금, 2006 – 07 – 21 04:28
더 보기

[미국 연방무역위원회] 특허기간 중 제네릭 시장 진입 제도 연구보고서(2002년)

미국은 식약청이 의약품을 허가하는 과정에서 특허권 침해가 있는지를 판단하는 연계(linkage) 제도를 두고 있습니다. 이 제도는 특허권이 만료되기 전

hurips – 수, 2006 – 07 – 19 01:27
더 보기

미국-태국 FTA 지적재산권 협상 조문

IPR text proposed by US to Thailand (2006)

US proposal on ‘patents’ and on ‘measures related to certain regulated products’ for negotiation with Thailand under the IPR chapter of the current US-Thailand FTA talks.

hurips – 수, 2006 – 07 – 19 01:22
더 보기

[Abbott 교수 논문] FTA의 지적재산권 조항과 미국 법률

미국 법률 규정에 비추어 FTA 지적재산권 조항들을 분석한 탁월한 논문입니다.

hurips – 수, 2006 – 07 – 19 01:19